Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Laboratory for Molecular Medicine, |
RCV000156254 | SCV000205970 | uncertain significance | not specified | 2017-09-12 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Benign. The p.Lys15140Val v ariant in TTN is caused by two adjacent nucleotide changes (c.45418A>G and c.454 19A>T) that are present in cis (on the same chromosome). This complex allele has been reported by our laboratory in 2 individuals (1 adult with HCM and 1 child with RCM), both of whom harbor pathogenic variants in other genes responsible fo r their symptoms. The c.45418A>G variant has been reported in 72/125502 European chromosomes and the c.45419A>T variant has been reported in 5% (1276/25784) of European chromosomes by the Genome Aggregation Database (http://gnomad.broadinst itute.org/; dbSNP rs185913848 and rs2303832). Computational prediction tools and conservation analysis suggest that the p.Lys15140Val variant may not impact the protein, though this information is not predictive enough to rule out pathogeni city. Additionally, the variant amino acid, valine (Val), is present in at leas t >10 bird species and several reptiles and fish species. In summary, while the clinical significance of the p.Lys15140Val variant is uncertain, collectively th ese data suggest that the p.Lys15150Val variant is more likely to be benign. |